MTOR and type 1 diabetes mellitus: The author also performed a study on a small sample of human subjects and on human pancreatic β-cells, which highlight that the inhibition of mTOR, along with PKA, promotes Ngn3-driven β-cell regeneration in human type 1 diabetes islets [43].